Drug intelligence / Profile preview

RDD1609

Development stage
Discontinued
Lead developer
RDD Pharma
Modality
Small Molecules, Hydrogel Systems → Drug Delivery Systems
Administration
Topical
01

Overview

RDD1609 is a topical gel formulation of pregabalin developed for the treatment of idiopathic pruritus ani, a condition characterized by chronic itching around the anus with no identifiable cause. The drug was investigated in randomized, double-blind, placebo-controlled phase 2 clinical trials to assess its efficacy and safety for this indication. Pregabalin is known as an anticonvulsant and neuropathic pain agent when used systemically; however, in this formulation it is applied locally as a gel. The precise mechanism of action for RDD1609 in pruritus ani remains unknown. The product was developed by RDD Pharma Ltd., but development has been discontinued following phase 2 studies[1][2][3][5].

Other names
Pregabalin Gel
02

Targets

α2δ (Voltage-gated calcium channel alpha-2-delta subunit)

Beyond the preview

Go deeper on RDD1609.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RDD1609.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call